JOSHUA SMITH: Open Payments
NPI 1750857504 · FISHERS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,289 in 84 payments from 15 companies in 2025. Trend: 2023 $1,999 · 2024 $1,454 · 2025 $2,289
Food & beverage: $2,289
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $604 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $388 |
| Janssen Biotech, Inc. | 7 | $297 |
| Lilly USA, LLC | 9 | $265 |
| Regeneron Healthcare Solutions, Inc. | 2 | $146 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $138 |
| Novo Nordisk Inc | 3 | $91 |
| Madrigal Pharmaceuticals | 1 | $90 |
| PFIZER INC. | 4 | $83 |
| QOL Medical, LLC | 3 | $53 |
Products named: RINVOQ, TREMFYA, OMVOH, ENTYVIO, DUPIXENT, XIFAXAN, GATTEX, Wegovy.
Industry payments across IN — which companies pay providers there.
